SIRT Yttrium-90
BTC001
Phase 2 small_molecule completed
Quick answer
SIRT Yttrium-90 for Cholangio Carcinoma is a Phase 2 program (small_molecule) at Chinese University of Hong Kong with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Chinese University of Hong Kong
- Indication
- Cholangio Carcinoma
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- completed